Evidence map›Paper›PMID 34652535›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2022

Preoperative atropine and non-steroidal anti-inflammatory drugs for the prevention of intraoperative floppy iris syndrome.

Tal Sharon, Idan Hecht, Maya Atar Vardi, Ron Eremenko, Ehud I Assia, Eran Pras, Margarita Safir

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tal SharonOphthalmology Department, Meir Medical Center, Kefar Sava, Israel.
Idan HechtSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Maya Atar VardiSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ron EremenkoSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ehud I AssiaOphthalmology Department, Meir Medical Center, Kefar Sava, Israel.
Eran PrasSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Margarita SafirSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. sapir.margarita@gmail.com.ORCID http://orcid.org/0000-0002-1814-8316
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo examine the efficacy of preoperative administration of topical atropine 1% and non-steroidal anti-inflammatory drugs (NSAIDs) for prevention of intraoperative floppy iris syndrome (IFIS).

methodsIn this retrospective cohort study, patients who underwent cataract surgery by phacoemulsification between July 2019 and February 2020 in two hospitals were included. Both hospitals are located in central Israel, have similar patient demographics and employ similar surgical techniques. They, however, differ in policy of IFIS prevention. In Meir Medical Center no preventive medications are given pre-operatively, while in Shamir Medical Center patients at-risk for IFIS receive topical atropine 1% once daily and non-steroidal anti-inflammatory drugs (NSAIDs) thrice daily for 3 days preoperatively.

resultsOverall, 207 eyes of 207 patients with history of alpha-antagonist use were included. Mean age was 74.9 ± 7.8 years and 82.1% (n = 170) were male. Among patients from the pretreating center 86.8% (n = 92/106) were pre-treated with either NSAIDs or atropine preoperatively, while in the non-pretreating center no treatment was prescribed (n = 0/101). IFIS rate among the non-pretreating center was 29.7% (n = 30/101) compared to 15.1% (n = 16/106) in the pretreating center (p = 0.012). When strictly comparing treated to untreated patients, the treated group had an IFIS rate of 12.0% compared to 30.4% among untreated (p = 0.001). Adjusted for age and gender results remain consistent (odds ratio 0.329 for treated patients, 95% confidence interval: 0.150-0.720; p = 0.005).

conclusionsIFIS rates were significantly lower in the pretreating center compared to the non-pretreating center. When comparing strictly treated to untreated patients, differences were even more pronounced.

Indexed as

Iris DiseasesPhacoemulsificationPharmaceutical PreparationsAdrenergic alpha-1 Receptor AntagonistsAgedAged, 80 and overAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAtropineHumansIncidenceIntraoperative ComplicationsIrisMaleRetrospective StudiesSulfonamidesAdrenergic alpha-1 Receptor AntagonistsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAtropinePharmaceutical PreparationsSulfonamidesTamsulosinAtropineCataract surgeryIntraoperative floppy eyelid syndromeNon-steroidal anti-inflammatory drugs

Identifiers

PMID34652535
OpenAlexW3207959989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.